 |
Hepatitis C virus immune globulin (human) |
|---|---|
| Trade Name | Civacir(Tm) |
| Orphan Indication | Prophylaxis of hepatitis C infection in liver transplant recipients |
| USA Market Approval | USA |
| USA Designation Date | 2002-11-14 00:00:00 |
| Sponsor | ADMA Biologics, Inc.;465 Route 17 South;Ramsey, New Jersey, 07446 |
